Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra.

Acta neuropathologica

Volumn 112, Issue 2, 2006, Pages 115-126

  Galvin, James E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETALDEHYDE; 3,4 DIHYDROXYPHENYLACETIC ACID; 3,4-DIHYDROXYPHENYLACETALDEHYDE; ALPHA SYNUCLEIN; DOPAMINE; DRUG DERIVATIVE;

HUMAN; METABOLISM; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ALPHA-SYNUCLEIN; DOPAMINE; HUMANS; OXIDATIVE STRESS; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 33750284754     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-006-0096-2     Document Type: Review

References (114)